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Results There were no significant differences (p > 0.05) identified between the 25 presence or absence of laryngeal motion between dogs administered propofol or 26 alfaxalone, as well as when analysing non-brachycephalic and brachycephalic dogs 27 separately. The majority of dogs (>75%) maintained some degree of laryngeal motion 28 with both protocols. Agreement between assessors was excellent (κ = 0.822). 29
Conclusions Alfaxalone maintained laryngeal motion similarly to propofol in non-30 brachycephalic and brachycephalic dogs. 31
Clinical relevance Both agents would appear appropriate for allowing assessment of 32 laryngeal motion in non-brachycephalic and brachycephalic dogs. The assessment 33 technique of subjective evaluation of laryngeal motion via per oral laryngoscopy under 34 a light plane of anaesthesia produced consistent results amongst assessors, regardless of 35
Introduction 39
Normal laryngeal motion, which is used as an indicator for laryngeal function, is 40 demonstrated by the abduction of the arytenoid cartilages during inhalation and passive 41 relaxation during exhalation (Gross et al. 2002) . Peroral laryngoscopy under a light 42 plane of anaesthesia is the most widely used clinical method for interpretation of 43 laryngeal motion in dogs with 95% interobserver agreement (Broome et al. 2000; 44 Radlinsky et al. 2009; Smith 2000) . The ideal anaesthetic protocol should provide 45 relaxation of the jaw muscles, maintenance of laryngeal reflexes and minimal 46 respiratory depression (McKeirnan et al. 2014) . 47 M A N U S C R I P T
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A previous study by Jackson et al. (2004) concluded that intravenous thiopental given to 49 effect was the best choice for assessing laryngeal motion in dogs. Significantly greater 50 arytenoid motion was demonstrated after thiopental administration when compared with 51 other anaesthetic protocols (propofol, ketamine, diazepam and acepromazine). Although 52 thiopental remains a useful agent in veterinary anaesthesia, it is no longer licensed in 53 veterinary species and has therefore been largely replaced by propofol (Clarke et al. 54 2014) . 55 56 Alfaxalone is a synthetic neurosteroid that at high concentrations acts as a direct agonist 57 of the GABA A receptor (Berry 2015) . It is used in veterinary practice as an induction 58 agent for anaesthesia. Minimal studies regarding this drug's effect on laryngeal motion 59 and function have been published up until now, especially in a clinical setting. A paper 60
by Smalle et al. (2017) concluded that there was no significant difference in the total 61 number of arytenoid motions after administration of thiopental, propofol or alfaxalone 62 in six research dogs. Nelissen et al. (2012a) also identified no significant difference in 63 arytenoid cartilage motion evaluating healthy cats using video laryngoscopy after 64 administration of alfaxalone, propofol or midazolam/ketamine. On the other hand, a 65 paper looking at the efficacy and safety of alfaxalone in humans (Monagle et al. 2015 ) 66 identified significantly less airway obstruction and therefore better airway patency after 67 alfaxalone administration compared to propofol. 68 69 Laryngeal paralysis is a common airway disorder in large breed dogs (Holt & Brockman 70 1994; Burbridge 1994) that is diagnosed via subjective airway assessment. It is vital to 71 use an induction agent that maintains laryngeal motion in suspect cases to increase 72 objectivity and accuracy of the assessment method. Moreover, an anaesthetic agent thatM A N U S C R I P T
maintains laryngeal motion will provide a patent rima glottidis during induction 74 allowing persistent oxygen flow. This may prove safer, especially in breeds where 75 difficult intubation is more likely to occur. Brachycephalic breeds often have congenital 76 defects such as narrowed nares, an overlong soft palate, tracheal hypoplasia and 77 excessive laryngeal tissue (De Lorenzi et al. 2009)] . These defects impose a much 78 higher risk of airway occlusion and secondary hypoxia especially during induction of 79 anaesthesia, before successful intubation has occurred. 80
81
The main aim of this study was to assess whether laryngeal motion was present or 82 absent under a light plane of anaesthesia after injecting either alfaxalone or propofol. 83
This was evaluated in a cohort of non-brachycephalic and brachycephalic dogs, prior to 84 routine surgical procedures performed in a university referral hospital. The second aim 85 of this study was to evaluate the degree of inter-observer variability when using peroral 86 laryngoscopy for assessment of laryngeal motion. intravenous (IV) catheter was placed in a peripheral vein and a sedation score using a 113 simple descriptive scale ranging from 0 (no change from pre-sedation behaviour) to 3 114 (very heavily sedated, unable to walk) (Table 1) was assigned. 115
The maximum dose of each induction agent (propofol 4 mg kg -1 or alfaxalone 116 2 mg kg -1 ) were calculated for each animal, drawn up and kept hidden. Each drug's 117 dose was chosen following the data sheets' recommendation in premedicated dogs. 118 Estimated lean body weight was used in severely overweight dogs. Prior to the arrival 119 of the assessor, a drape was placed over the IV catheter site to allow the induction agent 120 to be concealed from everyone in the room apart from the injector.
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anaesthesia was achieved; characterized by easy visual access to the larynx, persistence 124 of breathing and the maintenance of a gag reflex. Each increment was administered by 125 hand over 10 seconds with a 20-second pause before the next increment was injected. 126
An experienced board certified small animal specialist surgeon (GTH) was present at 127 each induction and assessed the airway using peroral laryngoscopy. The laryngeal exam 128 was performed by placing the dog in sternal recumbency, holding open the upper jaw to 129 expose the oral cavity, pulling the tongue forward and depressing the base of the tongue 130 just below the epiglottis (epiglottic vallecular) using a laryngoscope. If the plane of 131 anaesthesia was deemed too deep by the surgeon (GTH) for immediate laryngeal 132 assessment, the dog's oral cavity was closed and flow by oxygen was provided whilst 133 being under constant observation from the anaesthetist and surgeon. As soon as the 134 respiration rate increased, the surgeon (GTH) would attempt another laryngeal exam 135 ensuring the return of the gag reflex before beginning the assessment. In each dog 136 laryngeal motion was simply assessed as being either present or absent. This was 137 determined by the degree of arytenoid abduction during inspiration and the amount of 138 rima glottidis observed (Table 2) . 139
During the assessment, a short (30 -60 second) video was also made of the larynx 140 using an iPhone 6s over at least 4 respiratory cycles, which was to be used later for re-141 evaluation of laryngeal motion. Following this, the dog was given more induction agent 142 to allow intubation and was no longer followed for the purposes of the study. 
anaesthetic that allowed laryngeal assessment in all dogs was 1.9 (0.9 -5.1) mg kg -1 for 174 group P and 0.5 (0.2 -1.9) mg kg -1 for group A. The dose of injectable anaesthetic 175 agent to allow intubation in all dogs was 3.0 (1.1 -6.9) mg kg -1 for group P and 2.0 (0.5 176 -3.0) mg kg -1 for group A. 177
178
Overall the maintenance of some degree of laryngeal motion was identified in a large 179 majority of cases regardless of the induction agent used or whether the dog was non-180 brachycephalic or brachycephalic. During the initial assessment (Fig. 2) , 75% of dogs 181 were evaluated as having laryngeal motion present. During the collaborative assessment 182 (Fig. 3) with the speed of administration of the injectable anaesthetic agent contributing heavily 239 to this. The preservation of the respiratory cycle is necessary to determine accurate 240 arytenoid motion. Rapid IV injection (less than 5 seconds) of propofol and alfaxalone 241 commonly resulted in post-induction apnoea (Amengual et al. 2013) . In this study, the 242 anaesthetic agent was given slowly to effect in incremental doses. Another possible 243 method of administration would have been via a constant rate infusion using a syringe 244 driver. This method, in theory, should titrate the injectable anaesthetic agent more 245 precisely allowing the desired level of anaesthesia for laryngeal assessment to beM A N U S C R I P T
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anaesthetic agents for assessing laryngeal motion (Nelissen et al. 2012a) , assessment 248 and intubation doses in all the cats were the same suggesting that the appropriate point 249 at which to assess had already been surpassed. From a practical point of view, the 250 method of administration performed in this study required less equipment and is more 251 reflective of common clinical practice. 252
253
Both the use of ACP as part of the premedication and the incremental injection of the 254 chosen anaesthetic agent in this study, are factors that in theory would reduce laryngeal 255 motion. Therefore, it would be expected to identify more dogs with the absence of 256 laryngeal motion than truly present. However, despite these factors the majority of dogs 257 (>75%) maintained some degree of laryngeal motion in both the propofol and 258 alfaxalone group, suggesting that they had minimal impact. Moreover, this result 259 supports the use of either injectable anaesthetic agent for laryngeal assessment. 260
261
A potential limitation in this study was the use of a scoring system with minimal 262 categories. Smalle et al. (2017) used a much more extensive scoring system comprising 263 of four categories each with two subcategories. Although not validated, the scoring 264 system utilized in this study was adopted from previous studies and adjusted using the 265 grading system for laryngeal function in non-sedated horses (Gross et al. 2002; 266 Robinson 2004; McKeirnan et al. 2014) . While no significant difference was found in 267 that study between thiopentone, propofol and alfaxalone, with the much larger subject 268 numbers used in the current study, a potential difference between anaesthetic agents and 269 laryngeal motion may have been detected. 270 M A N U S C R I P T
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The third intermediate category (minimal laryngeal movement) for the reassessment of 272 the airways was not part of the original study protocol. However, after the initial data 273 collection it was apparent that some dogs had very obvious laryngeal motion and some 274 had minimal. The justification to implement this additional category was to potentially 275 identify a significant difference between obvious and subtle laryngeal motion and 276 whether this could be attributed to either anaesthetic agent, possibly providing some 277 clinical benefit. Due to this alteration, intra-observer variability could not be 278 determined. 279
280
Another limitation of the study was that thiopental was not used as a comparative 281 induction agent. Thiopental has historically been considered the best choice for the 282 assessment of laryngeal motion (Jackson et al. 2004 ) and therefore novel induction 283 agents should be compared to it. However, no licenced thiopental product is available 284 for veterinary patients in the EU or UK, therefore its use could not be justified in 285 clinical patients. Moreover, the fact that thiopental is no longer available gives more 286 reason to find a comparable, accessible alternative for laryngeal assessment. 287
288
To the knowledge of the authors, this is the first study to assess the effect of different 289 anaesthetic agents on laryngeal motion in brachycephalic as well as non-brachycephalic 290 dogs. Therefore, an appropriate assessment technique for evaluating laryngeal motion in 291 a cohort of dogs with such a grossly altered respiratory anatomy has not been described 292 before and there may be other factors that should be taken into account when trying to 293 make an accurate assessment. For example, we know that a majority of brachycephalic 294 dogs present with some degree of laryngeal collapse (Monet and Tobias 2012). The 295 effect of laryngeal collapse on laryngeal motion has not been reported although theM A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT incident of both pathologies co-occurring has been described (Nelissen and White 297 2012b) . The degree of laryngeal collapse was not recorded in this study; therefore, it is 298 difficult to determine whether this variable had any impact on the results obtained. 299
Future studies could focus on specific laryngeal assessment in the brachycephalic 300 population, the impact of laryngeal collapse on laryngeal motion and if our current 301 assessment measures for laryngeal motion are even applicable to brachycephalic dogs as 302 they have so many airway malformations. Table 3 Demographic and other data of all dogs included in this study. Anaesthesia was 401 induced with either propofol (0.9 -6.9 mg kg -1 ) (group P all dogs, n = 24; group P non-402 brachycephalic dogs, n = 12; group P brachycephalic dogs, n = 12) or alfaxalone (0. Tables   Table 1 Description Table 2 Descriptors used for assessing laryngeal motion.
Assessment answer Description
Obvious 
Table 3
Demographic and other data of all the dogs in this study. Anaesthesia was induced with either propofol (0.9 -6.9 mg kg -1 ) (group P all dogs, n = 24; group P nonbrachycephalic dogs, n = 12; group P brachycephalic dogs, n = 12) or alfaxalone (0.2 -3.0 mg kg -1 ) (group A all dogs, n = 24; group A non-brachycephalic dogs, n = 12; group A brachycephalic dogs, n = 12). 
Dogs

